Showing posts with label Silent stroke. Show all posts
Showing posts with label Silent stroke. Show all posts

Monday, 20 August 2018

Research explores relationship between fever and cancer occurrence

In a new study, scientists have explored the relationship between fever and cancer incidence.
Image result for fever and cancer
The recurring patterns in patient accounts suggest the existence of an inverse relationship between the history of infectious fever and cancer risk which are documented throughout decades of medical literature.
However, evidence supporting this correlation continues to be primarily anecdotal.
Drawing upon previous research and experimental data, the authors argue that repeated exposure to fever enhances the ability of gd T cells to detect cellular abnormalities and to foster inhospitable environments that destroy malignant cells.
This paper is the first to acknowledge the role that gd T cells may play as participants in this inverse relationship.
Infectious fever is the defensive and adaptive reaction that occurs when an organism’s immune system comes into contact with exogenous pyrogens, or pathogen-associated molecular pattern (PAMP). Upon recognition of these exogenous pyrogens, endogenous mediators–also known as endogenous pyrogens–engage the febrile system.
The authors further elaborate on the function of endogenous mediators, like cytokines.
“In short, endogenous mediators of fever redirect metabolic substrates and energy to the immune system during fever. This markedly enhances the frequency of a vast range of immune effectors, including lymphocytes expressing gd heterodimer receptors, which possess a potent anti-infectious and antitumor competence,” wrote authors.
Article Source : BS

Link discovered between inflammation and depression in type 1 diabetes

Inflammatory protein is associated with depression in diabetes, according to a study.
Image result for Link discovered between inflammation and depression in type 1 diabetes
The research, conducted by at Lund University in Sweden, suggests that galectin-3 levels may be useful for diagnosis of depression or may be a new target for treating depression associated with type-1 diabetes, which could lead to better patient care.
It is well established that people with both type-1 and type-2 diabetes have an increased risk of developing depression, a debilitating mental health disorder with potentially serious consequences, but the causes remain poorly understood.
Galectin-3 is a key protein involved in promoting inflammatory immune system responses that are needed to repair tissue damage throughout the body, in response to injury or disease. However, elevated levels of galectin-3 have also been linked to an increased risk of inflammatory disorders including Alzheimer’s disease and cardiovascular disease. Previous research has suggested that both depression and diabetes may be associated with increased levels of inflammation in the body but the role of galectin-3 has not been investigated in either condition.
In this study, Dr Eva Olga Melin and colleagues measured the galectin-3 levels of 283 men and women, aged 18-59, with type-1 diabetes, for at least one year. Incidence of depression in these patients was self-reported and assessed using the Hospital Anxiety and Depression Scale-Depression subscale and possible confounding influences of lifestyle factors including heart disease, smoking or poorly managed diabetes were accounted for in the analysis. The researchers found that both men and women with type-1 diabetes and depression also had significantly higher galectin-3 levels.
Dr Melin commented, “We found that people with type-1 diabetes and depression had higher galectin-3 levels, yet no other diabetes-related metabolic changes could account for these elevated levels.”

Article Source : BS

14th BRICS summit to review current global issues, reach key agreements

  At the   14th BRICS summit   which is to be hosted by China in a virtual mode on 23-24 June, the member nations will review the current gl...